In partnership with
Yes, that Arnold Schwarzenegger.
He has a newsletter on beehiiv. So do Codie Sanchez, Jay Shetty, David Begnaud, Colin & Samir, and Joanna Stern.
They could publish just about anywhere. They chose beehiiv to build a direct connection with the people who want to hear from them most. And you can do the same, whether you’re world-famous or just at the start of your plan for world domination.
When it comes to managing a rare disease, families often face overwhelming challenges and daunting medical costs. But sometimes, their determination can lead to breakthroughs that change lives. That's exactly what happened with one family's mission to tackle Sanfilippo syndrome, a rare genetic disorder, resulting in the FDA approval of a revolutionary gene therapy.
Sanfilippo syndrome is a rare inherited condition that affects a child's ability to break down a specific molecule needed for normal cell function. Without treatment, it leads to severe complications, including loss of speech and mobility, seizures, and a significantly shortened lifespan. Most children with this condition don't live past their teenage years.
For the O'Neill family, the diagnosis of their daughter Eliza was a turning point. They quickly realized the urgency of the situation and decided to take action to find a treatment.
The Power of Community and Fundraising
Faced with the grim reality of Sanfilippo, the O'Neills harnessed the power of community support. They created a viral video campaign that quickly gained traction, raising millions of dollars to fund research. This effort broke records on platforms like GoFundMe, showing that collective action can fuel scientific advances.
The funds raised were crucial in supporting the first human trial of a new gene therapy, which had been under development since the late 1990s. Without this community-driven financial push, the research might have stalled.
Gene Therapy Breakthrough
The gene therapy, developed by researcher Haiyan Fu, uses a modified virus to deliver a working copy of the faulty gene to patients' cells. The therapy showed promise in early trials, particularly when administered to very young children, who still have significant brain function to preserve.
In 2022, biotech company Ultragenyx took the research further, ultimately leading to FDA approval in September. This new treatment, called Fayuvi, offers a potentially life-changing option for affected families.
Cost and Accessibility Concerns
While the approval of Fayuvi is a significant milestone, the cost remains a concern. Priced at nearly $4 million, it ties as one of the most expensive gene therapies available. However, Ultragenyx has committed to ensuring access regardless of financial barriers, promising that logistical or financial challenges will not prevent treatment.
Families facing similar challenges can take heart in knowing that there are pathways to push for treatments, even when costs are high. Exploring options like drug discount cards, such as the RxGo free drug discount card at RxGo, can help manage prescription expenses.
What This Means For You
Stay Informed: Keep up with the latest treatments and research developments related to your condition.
Leverage Community Support: Engage with patient foundations and support groups for resources and fundraising ideas.
Explore Financial Assistance: Look into programs and discounts that can help offset treatment costs.
Advocate for Early Diagnosis: If you suspect a rare condition, push for early testing to maximize treatment options.
Consider Genetic Counseling: It can provide insight into hereditary conditions and inform family planning decisions.
The journey of the O'Neill family is a testament to the impact of perseverance and community. As more treatments become available, the focus will shift to ensuring they are accessible to all who need them. Keep advocating and exploring resources to manage your health journey effectively.
